Search

Decreased sound tolerance in autism: understanding and distinguishing between hyperacusis, misophonia, and phonophobia

Decreased sound tolerance (DST) affects a significant proportion of autistic people throughout their lifetime and, as Zachary J Williams explains, it is important that clinicians are aware of the three distinct subtypes of DST when making a diagnosis. Autism spectrum...

Audiological management of autistic children

Philippa James and Lucy Shiels explain the development of the ‘Autism Listening Clinics’, highlighting a recommended clinical approach for audiologists, the importance of remote microphone technology and sharing some wonderful caregiver experiences. Auditory challenges in autistic children Autism spectrum disorder...

Implicit bias in audiology and wider healthcare

What is implicit bias and how might it affect patient outcomes in hearing healthcare? Yovina Khiroya provides insight into the terminology and the effect on people and service delivery. As much as possible within healthcare, we try to reduce implicit...

Current management of unilateral sporadic vestibular schwannoma

Vestibular schwannoma is the commonest tumour of the cerebellopontine angle (80%) and accounts for around 8% of all intracranial tumours. The commonest primary presenting symptoms are audio vestibular. Hearing health professionals are often the first contact for patients with potential symptoms of vestibular schwannoma, with the majority then being seen and diagnosed by otorhinolaryngologists.

Adult speech testing in the UK

What do hearing healthcare providers see as the benefits and barriers to delivering speech testing? This article explores the latest research. Why speech testing? Speech tests have been used across ENT and audiology practice to measure an individual’s speech recognition...

The changing landscape for hearing loss therapeutics: novel advances of gene and cell therapies

Recent years have seen advances in hearing loss therapeutics, with novel treatments trialled in humans, and others nearing promising first-in-kind clinical trials. First successful clinical trials for a specific form of genetic hearing loss Very exciting news has emerged in...

Understanding the NAL-NL3 Prescription System: a new era of personalised hearing aid fitting

The NAL-NL3 system marks a transformative step in hearing aid fitting, shifting from a one-size-fits-most prescription to a modular, patient-centred approach. Developed by the National Acoustic Laboratories, this new system integrates a core audiogram-based prescription with targeted modules to address...

Multi-channel cochlear implants: past, present and future

Forty years since the first multi-channel devices were implanted, who better than Ingeborg Hochmair, who has been a key figure throughout their evolution, to offer her thoughts on the past, present and future of multi-channel cochlear implants? Read on for...

Cochlear implantation in the developing world: perspectives from the Indian subcontinent

Cochlear implants are an expensive technology, yet profound hearing loss is far from a developed-world phenomenon. On the contrary, incidences of both congenital and acquired hearing losses are high in the developing world. This article explains how an initiative in...

Surgeons and swearing

We will all know colleagues who have raised the act of swearing to an art form; just as Malcolm Tucker in The Thick of It could cut a workmate in half with a well-placed swear word, surgeons can be equally...

Discovery in the genetics of complex disease: Otitis media

Otitis media (OM), a common disease of childhood, is considered to be a complex trait with multiple genetic and environmental factors expected to contribute to a child’s risk of developing recurrent acute OM (rAOM; ≥3 episodes in 6 months or...